Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In France, venous thromboembolic (VTE) disease is usually managed by vascular medicine physicians (VMP). The national OPTIMEV study, conducted more than 12 years ago among VMP practicing in hospital and in the community described the management of VTE in routine clinical practice. Since then a large number of practice changing studies have been published. This includes trials that have validated the use of direct oral anticoagulants (DOAC), the new standard of care of VTE, as per new national and international guidelines. Management of VTE in 2019 appears to be significantly different from the one that prevailed more than 10 years ago when the last national survey was conducted. It is therefore important to have an update on the routine clinical practice management of VTE by VMP. In this perspective the investigators aim to conduct a national survey among VMP practicing in France
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| VMP members of the SFMV | VMP (vascular medicine physicians) members of the SFMV (French Society of Vascular Medicine ) | ||
| VMP registered as willing to do medical research | VMP (vascular medicine physicians) registered as willing to do medical research |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Inter-practician variability of clinical care of venous thromboembolic in routine clinical practice | The variation in venous thromboembolic management in routine clinical practice is assessed by analysing the management of the 5 consecutive acute venous thromboembolic patients reported by each participating physician | up to 3 months after inclusion |
| Measure | Description | Time Frame |
|---|---|---|
| Inter-practician variability of clinical care of venous thromboembolic according to patient age | patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk | up to 6 months after inclusion |
| Inter-practician variability of clinical care of venous thromboembolic according to patient body weight |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Vascular medicine physicians (VMP) practicing in the hospital and in the community settings.
Participating VMP will prospectively collect data on the management of incident venous thromboembolic (VTE) disease cases.
After that, vascular medicine physicians will answer a phone questionnaire on their general VTE management
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Simon Soudet, MD | CHU Amiens | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Amiens | Amiens | 80480 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D054556 | Venous Thromboembolism |
| D020246 | Venous Thrombosis |
| D011655 | Pulmonary Embolism |
| ID | Term |
|---|---|
| D013923 | Thromboembolism |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk |
| up to 6 months after inclusion |
| Inter-practician variability of clinical care of venous thromboembolic according to patient bleeding risk | patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk | up to 6 months after inclusion |
| D013927 |
| Thrombosis |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D004617 | Embolism |